ArticleTranslational gastroenterology and hepatology2025
Anatomical S5 segmentectomy for regional cholangitis due to bile duct injury: versatile applications of indocyanine green (with video).
Article in Translational gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iatrogenic bile duct injury (BDI) is a serious complication that affects patients' quality of life and survival. Surgical resection of the hepatic segment affected has been reported. We describe a case of anatomical resection of segment 5 (S5) using multiple applications of indocyanine green (ICG) fluorescence imaging. A 46-year-old female with BDI during laparoscopic cholecystectomy performed in 2010 was referred to Osaka Metropolitan University Hospital due to recurrent cholangitis. Abdominal computed tomography (CT) scan and magnetic resonance cholangiopancreatography (MRCP) identified stumps on bile duct draining segment 5 (B5s), significantly dilated, suggestive of sclerosing cholangitis. Drainage of B5s was not feasible via endoscopic approach and surgical resection of S5 was indicated. ICG (0.5 mg/kg) was administered 3 days prior to surgery [indocyanine green retention rate at 15 minutes (ICGR15): 3.6%]. After an inverted L-shaped incision, atrophic regions of S5 were identified by naked-eye examination and more clearly by near-infrared imaging. Intraoperative ultrasound also identified biliary dilatations in non-fluorescing regions of S5, which suggested abnormal biliary drainage surrounding the atrophic area. In order to remove whole responsible legions causing cholangitis, we decided to indicate anatomic resection of S5 with the use of positive staining technique. The medial and the cranial branch of S5 portal vein (P5) were punctured and stained (0.25 mg ICG mixed with indigo-carmine). Fluorescence imaging delineated S5, including the atrophic area. Hepatic parenchyma was transected using the clamp-crash method under Pringle maneuver. The two major branches of P5 stained previously were identified and ligated. Finally, the root of the dilated hepatic ducts with complete obstruction were identified and divided, 1 cm distal to metal clips. Fluorescence imaging was used to confirm the removal of all stained regions. Then, ICG (1.25 mg) was administered to confirm blood perfusion of the remaining hepatic parenchyma. No bile leaks were identified by naked-eye examination or fluorescence imaging. Postoperative course was uneventful and patient was discharged on day 8. This technique underscores the multifaceted applications of indocyanine green in liver surgery, from preoperative planning and intraoperative guidance to postoperative assessment, thereby enhancing the safety and efficacy of hepatic resections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.